Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-02

FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)

View source ↗

Summary

FDA approved a supplemental NDA for Verapamil Hydrochloride from Exela Pharma Sciences, LLC under NDA 018925.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verapamil Hydrochloride (Verapamil hydrochloride)

Snippet

SUPPL AP for VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE)